NIBEC is a venture firm established in 2004 for R&D and manufacture of tissue regeneration devices. NIBEC aims to research innovative ideas for tissue regeneration treatments and to develop and manufacture devices for practical use.
Along with other professors of School of Dentistry at Seoul National University, Chong-pyoung Chung, Ph.D, began research on activating the surface of the biomaterials used in dentistry and surgery to modify cells at will. With Chong-pyoung Chung acting as Director, NIBEC was founded to manufacture these results into products for commercial use.
Securing technology as a growth engine for the future
NIBEC derived its name from nanotechnology and biotechnology, which it aims to combine in its development of products. NIBEC is conducting R&D into a product which combines peptide engineering for activating the surface of biomaterials and drug delivery methods.
This field pertains to the fields of functional rehabilitation, medical welfare technology and nano-material design among the 80 fields labelled as engines for future growth, and is being nurtured concertedly all over the world. NIBEC is also expected to secure competitive advantage in this cutting-edge field shortly through concentrated investment in technology and R&D.
In March 2004, NIBEC founded a central research center for greater efficiency in its work of inspecting new treatment techniques and developing the product for mass production. The research center has been certified as a affiliated agency by Korea Industrial Technology Association.
Hence, in addition to conducting its own R&D into medical devices for tissue regeneration, NIBEC has also been working to translate the technical expertise gleaned from its cooperation with the academia into products for commercial use.
NIBEC has stated “Our products are the result of years of research and testing, and must be licensed by the KFDA. We will strive to create products that meet expectations for top-quality cutting-edge products. We are currently focusing on R&D for products used in dentistry, but we fully intend to expand our research to products for cosmetic surgery, orthopedics and beyond.“
From these achievements, NIBEC will step-up to the development of peptide new drugs. Finally, NIBEC will be a global leader for peptide smart material development.
Bio-industry, the global leader in ‘NIBEC’
Age of Beck’s research will continue for a brighter tomorrow. Unremitting efforts Graduate School of human health and the pursuit of happiness.